Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Do atypical antipsychotics cause stroke?

Herrmann N, Lanctôt KL.

CNS Drugs. 2005;19(2):91-103. Review.

PMID:
15697324
2.

[Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].

van Marum RJ, Jansen PA.

Ned Tijdschr Geneeskd. 2005 Jan 22;149(4):165-7. Dutch.

PMID:
15702733
3.

Atypical antipsychotics and risk of cerebrovascular accidents.

Herrmann N, Mamdani M, Lanctôt KL.

Am J Psychiatry. 2004 Jun;161(6):1113-5.

PMID:
15169702
5.

Antipsychotics for delirium.

Lonergan E, Britton AM, Luxenberg J, Wyller T.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005594. Review.

PMID:
17443602
6.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
7.

Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.

Chiabrando G, Bianchi S, Poluzzi E, Montanaro N, Scanavacca P.

Eur J Clin Pharmacol. 2010 Jul;66(7):661-9. doi: 10.1007/s00228-010-0828-z. Epub 2010 May 13.

PMID:
20464383
8.

[Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review].

Zuidema SU, van Iersel MB, Koopmans RT, Verhey FR, Olde Rikkert MG.

Ned Tijdschr Geneeskd. 2006 Jul 15;150(28):1565-73. Review. Dutch.

PMID:
16886695
9.

The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.

Ballard C, Waite J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003476. Review.

PMID:
16437455
10.

A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.

Kryzhanovskaya LA, Jeste DV, Young CA, Polzer JP, Roddy TE, Jansen JF, Carlson JL, Cavazzoni PA.

J Clin Psychiatry. 2006 Jun;67(6):933-45.

PMID:
16848653
11.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
12.

Off-Label Use of Atypical Antipsychotics: An Update [Internet].

Maglione M, Maher AR, Hu J, Wang Z, Shanman R, Shekelle PG, Roth B, Hilton L, Suttorp MJ, Ewing BA, Motala A, Perry T.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep.

13.

Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.

Schneider LS, Dagerman K, Insel PS.

Am J Geriatr Psychiatry. 2006 Mar;14(3):191-210.

PMID:
16505124
14.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
15.

[Atypical antipsychotics in elderly patients with dementia].

Selbaek G, Engedal K.

Tidsskr Nor Laegeforen. 2008 May 1;128(9):1060-1. Norwegian.

16.

Mortality in elderly dementia patients treated with risperidone.

Haupt M, Cruz-Jentoft A, Jeste D.

J Clin Psychopharmacol. 2006 Dec;26(6):566-70.

PMID:
17110812
17.

Drug Class Review: Atypical Antipsychotic Drugs: Final Update 3 Report [Internet].

McDonagh M, Peterson K, Carson S, Fu R, Thakurta S.

Portland (OR): Oregon Health & Science University; 2010 Jul.

18.

Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics.

Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V, Bernabei R.

J Clin Psychiatry. 2005 Sep;66(9):1090-6.

PMID:
16187764
19.

[The use of antipsychotics in patients with dementia].

Forlenza OV, Cretaz E, Diniz BS.

Rev Bras Psiquiatr. 2008 Sep;30(3):265-70. Review. Portuguese.

20.

Supplemental Content

Support Center